Strive, a Nasdaq-listed company, purchased 3,311 Bitcoin between October 5 and 9 for about $280 million at an average price of $84,500 per coin. This acquisition increased its Bitcoin holdings from 29,462 to 32,773 BTC, marking a more than 10% growth in just one week. The purchase significantly outpaced Strategy's recent 250 BTC addition. Strive funded part of the purchase through stock sales and cash, while also increasing its cash reserves to $310.3 million. The company continues to pursue a corporate Bitcoin treasury strategy, signaling strong confidence in Bitcoin as a corporate asset.
Strive's recent $280 million Bitcoin purchase provides context for cryptocurrency market activity. For readers following crypto, here is Pluang's market snapshot as of Oct 14, 2026 00:03 WIB: Of 50 major cryptocurrencies priced on Pluang, 16 rose and 33 fell. Notable movers include AXS at Rp20.440 with a 1-day change of -4.83% and Pluang order activity of 94% Sell / 6% Buy, COTI at Rp224 with -4.79% and 25% Sell / 75% Buy, and ZIL at Rp61 with -4.71% and 99% Sell / 1% Buy.
Domino's Pizza reported Q3 2026 earnings per share of $4.60, beating analyst expectations of $4.37, while revenue grew modestly by 3.4% to $1.19 billion. Same-store sales growth was minimal at 0.3% in the U.S. and 0.2% internationally, reflecting com...
Citigroup reported Q3 2026 earnings that exceeded analyst expectations, with EPS of $2.85 beating the $2.65 estimate and revenue of $23.8 billion slightly above forecasts. The bank's profit rose 40%, driven by exceptional fixed-income trading, invest...
State Street is set to report its Q3 2026 earnings with forecasts showing a 31.3% increase in earnings and 14% revenue growth, driven by strong net interest income and service fees. Despite record assets under management, higher operating and technol...
Restaurant Technologies, Inc. (RTI) released its 2026 Impact Report highlighting significant progress in sustainability and operational efficiency. In 2025, RTI recycled 393 million pounds of used cooking oil and delivered 719.4 million pounds of fre...
Over 60 companies are actively developing more than 65 medical marijuana therapies targeting conditions like chronic pain, neurological disorders, and cancer symptoms. Key drugs such as ZYN-002 and CardiolRx are in late-stage trials, with others in e...
